1.
Asia Pac Allergy
; 12(3): e27, 2022 Jul.
Article
in English
| MEDLINE | ID: covidwho-1988317
ABSTRACT
Urticaria is a common cutaneous adverse event from coronavirus disease 2019 vaccination. Previous studies hypothesized that excipients as polyethylene glycol in BNT162b2 vaccine and polysorbate in ChAdOx1 nCoV-19 vaccine are allergens. A 28-year-old woman had urticaria after a booster vaccination with BNT162b2 at the site of previous intradermal injection with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) spike protein. This reaction emphasized that delayed urticaria may not be an allergic reaction to excipient but rather to the immunogen as such as SARS-CoV-2 spike protein.
2.
JAAD Case Rep
; 18: 1-3, 2021 Dec.
Article
in English
| MEDLINE | ID: covidwho-1630331
3.
J Dermatol
; 47(12): e444-e446, 2020 Dec.
Article
in English
| MEDLINE | ID: covidwho-744671